GE Healthcare stock price closed at $77.98 yesterday, with RSI levels suggesting the asset is neither overbought nor oversold, leaving room for steady appreciation. However, in contrast to the optimism around technological advancements, investors should also be mindful of ongoing pressures from tariffs and supply chain challenges that... For the current fiscal year 2025, ending in December, analysts expect GEHC to report a 10.5% year-over-year decline in adjusted earnings to $4.02 per share. However, the company has an impressive earnings surprise history. It has surpassed the Street's bottom-line estimates in each of the past four quarters. GE Healthcare stock price traded near $78.45 in early market hours, reflecting a modest +0.6% intraday gain. Analysts note a bullish sentiment in the medical equipment sector driven by strong Q2 imaging device sales.
